Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05658796 · ClinicalTrials.gov registry record · NA

RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty

A NA study of Depression and Anxiety, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
3
Study locations

NCT05658796 is a NA study of Depression and Anxiety that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 150 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05658796, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
3
Study locations

Study Summary

It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-operative outcomes, improving saving for the UPMC ISD by hastening the recovery and decreased resource utilization, and addition to the high-value care of UPMC with this holistic approach to patient perioperative care

Interventions

  • BEHAVIORAL +RxWell
  • BEHAVIORAL -RxWell

Study Locations (3)

Pennsylvania

  • UPMC East - Monroeville
  • UPMC Shadyside - Pittsburgh
  • UPMC Passavant - Pittsburgh

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-01-27
Est. Completion 2026-12-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05658796

The ClinicalTrials.gov registry entry for NCT05658796 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which +RxWell is the first listed.

NCT05658796 reports 3 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05658796 about?

NCT05658796 is a clinical study titled "RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty". It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-ope...

What is the current status of trial NCT05658796?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-01-27. Estimated completion is 2026-12-30.

What conditions does trial NCT05658796 study?

This clinical trial studies the following conditions: Depression, Anxiety, Anxiety Disorders, Depressive Symptoms, Mood Disorders.

What interventions are being tested in trial NCT05658796?

The interventions under investigation include: +RxWell (BEHAVIORAL), -RxWell (BEHAVIORAL).

Who is sponsoring clinical trial NCT05658796?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05658796 being conducted?

This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.